TY - JOUR
T1 - Chemogenetic activation of nigrostriatal dopamine neurons in freely moving common marmosets
AU - Mimura, Koki
AU - Nagai, Yuji
AU - Inoue, Ken ichi
AU - Matsumoto, Jumpei
AU - Hori, Yukiko
AU - Sato, Chika
AU - Kimura, Kei
AU - Okauchi, Takashi
AU - Hirabayashi, Toshiyuki
AU - Nishijo, Hisao
AU - Yahata, Noriaki
AU - Takada, Masahiko
AU - Suhara, Tetsuya
AU - Higuchi, Makoto
AU - Minamimoto, Takafumi
N1 - Publisher Copyright:
© 2021 The Author(s)
PY - 2021/9/24
Y1 - 2021/9/24
N2 - To interrogate particular neuronal pathways in nonhuman primates under natural and stress-free conditions, we applied designer receptors exclusively activated by designer drugs (DREADDs) technology to common marmosets. We injected adeno-associated virus vectors expressing the excitatory DREADD hM3Dq into the unilateral substantia nigra (SN) in four marmosets. Using multi-tracer positron emission tomography imaging, we detected DREADD expression in vivo, which was confirmed in nigrostriatal dopamine neurons by immunohistochemistry, as well as by assessed activation of the SN following agonist administration. The marmosets rotated in a contralateral direction relative to the activated side 30–90 min after consuming food containing the highly potent DREADD agonist deschloroclozapine (DCZ) but not on the following days without DCZ. These results indicate that non-invasive and reversible DREADD manipulation will extend the utility of marmosets as a primate model for linking neuronal activity and natural behavior in various contexts.
AB - To interrogate particular neuronal pathways in nonhuman primates under natural and stress-free conditions, we applied designer receptors exclusively activated by designer drugs (DREADDs) technology to common marmosets. We injected adeno-associated virus vectors expressing the excitatory DREADD hM3Dq into the unilateral substantia nigra (SN) in four marmosets. Using multi-tracer positron emission tomography imaging, we detected DREADD expression in vivo, which was confirmed in nigrostriatal dopamine neurons by immunohistochemistry, as well as by assessed activation of the SN following agonist administration. The marmosets rotated in a contralateral direction relative to the activated side 30–90 min after consuming food containing the highly potent DREADD agonist deschloroclozapine (DCZ) but not on the following days without DCZ. These results indicate that non-invasive and reversible DREADD manipulation will extend the utility of marmosets as a primate model for linking neuronal activity and natural behavior in various contexts.
KW - behavioral neuroscience
KW - cellular neuroscience
KW - molecular neuroscience
UR - http://www.scopus.com/inward/record.url?scp=85116504416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116504416&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2021.103066
DO - 10.1016/j.isci.2021.103066
M3 - Article
AN - SCOPUS:85116504416
SN - 2589-0042
VL - 24
JO - iScience
JF - iScience
IS - 9
M1 - 103066
ER -